Trial Profile
Preventive sublingual immunotherapy for house dust mite sensitized preschool children
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 20 Jan 2017
Price :
$35
*
At a glance
- Drugs Grass pollen allergy immunotherapy (Primary)
- Indications Hypersensitivity
- Focus Therapeutic Use
- Acronyms The "PrevSens II" Trial
- 20 Jan 2017 New trial record